Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp Holdings (RAMP) Valuation As Shares Rebound In The Short Term

Event overview and why LiveRamp matters now LiveRamp Holdings (RAMP) is back on investors’ radar after recent share price moves, with the stock showing a mix of positive short term returns and weaker performance over the past year and five years. See our latest analysis for LiveRamp Holdings. LiveRamp’s recent 7 day share price return of 5.97% and 30 day share price return of 9.42% contrasts with a 1 year total shareholder return decline of 9.07%, which may indicate that short term momentum...
NYSE:TWO
NYSE:TWOMortgage REITs

UWM Deal Adds Uncertainty To Two Harbors Valuation And Dividend Outlook

UWM Holdings has agreed to acquire Two Harbors Investment Corp (NYSE:TWO), creating fresh questions for mortgage and mortgage servicing investors. Management at UWM has offered limited detail on how Two Harbors will be integrated, including capital allocation, portfolio positioning, and leadership roles. Investors are reacting to sparse guidance around timing, financial impact, and operational changes, especially given existing financial pressures at Two Harbors. Two Harbors focuses on...
ASX:VEA
ASX:VEAOil and Gas

A Look At Viva Energy Group (ASX:VEA) Valuation After Full Year 2025 Loss And Dividend Announcement

Viva Energy Group (ASX:VEA) has put investors on alert after releasing its full year 2025 results, pairing an ordinary fully franked dividend with a net loss, despite revenue remaining close to the prior year. See our latest analysis for Viva Energy Group. Viva Energy Group's share price has slipped recently, with a 30 day share price return of a 5.6% decline and a 90 day share price return of a 16.5% decline, even as investors weigh record commercial sales, new stores and a higher full year...
ASX:VAU
ASX:VAUMetals and Mining

Assessing Vault Minerals (ASX:VAU) Valuation After Half Year Loss And Confirmed Dividend

Vault Minerals (ASX:VAU) is back in focus after half year results showed sales of A$817.32 million alongside a net loss of A$35.23 million, as well as confirmed production figures and an upcoming ordinary dividend. See our latest analysis for Vault Minerals. At a share price of A$5.88, Vault Minerals has shown a 7.5% 7 day share price return and a 17.6% 90 day share price return. The 1 year total shareholder return of 123.36% and a very large 3 year total shareholder return suggest longer...
NasdaqGS:COCO
NasdaqGS:COCOBeverage

Assessing Vita Coco (COCO) Valuation After Mixed Quarter And Confident 2026 Guidance

Vita Coco Company (COCO) is back in focus after its latest quarter showed revenue ahead of expectations, while earnings per share came in slightly below consensus, alongside fresh guidance for fiscal 2026. See our latest analysis for Vita Coco Company. At a share price of $58.06, Vita Coco has seen positive momentum recently, with a 7 day share price return of 7.60% and a 90 day share price return of 8.71%, while its 1 year total shareholder return of 78.98% and 3 year total shareholder...
NYSE:YOU
NYSE:YOUSoftware

Clear Secure (YOU) Is Up 41.9% After Strong Cash Returns And Healthcare Push Has The Bull Case Changed?

Earlier this week, Clear Secure reported fourth-quarter and full-year 2025 results showing higher sales year over year, issued first-quarter 2026 revenue guidance of US$242–US$245 million, and announced both a 20% increase in its regular quarterly dividend to US$0.15 per share and a special US$0.20 per-share dividend alongside an expanded share repurchase authorization. The company also highlighted strong free cash flow generation, renewed its multiyear partnership with American Express, and...
TSX:OR
TSX:ORMetals and Mining

Assessing OR Royalties (TSX:OR) Valuation After Strong Recent Share Price Momentum

What recent performance tells you about OR Royalties With no single headline event driving attention, OR Royalties (TSX:OR) has still drawn interest as investors weigh its recent share performance, income profile, and royalty focused precious metals business model. The stock shows a 0.4% 1 day move, 8.2% over the past week, about 2% over the past month, and roughly 33% across the past 3 months, which frames the recent price context for your research. See our latest analysis for OR...
ENXTAM:THEON
ENXTAM:THEONAerospace & Defense

A Look At Theon International (ENXTAM:THEON) Valuation After 2026 Guidance And Dividend Policy Update

Theon International (ENXTAM:THEON) has drawn fresh attention after issuing 2026 revenue guidance of €570 million to €600 million, affirming a 20% to 30% payout of net income as dividends, and expanding its share liquidity agreement. See our latest analysis for Theon International. Against the flurry of 2026 guidance, dividend commitments and the enlarged liquidity agreement, Theon International’s 1 year total shareholder return of 85.6% stands out compared with its more modest 15.4% year to...
NYSE:KD
NYSE:KDIT

Has Kyndryl (KD) Fallen Too Far After IBM Separation To Ignore Its Valuation?

If you have been wondering whether Kyndryl Holdings is starting to look like value or a value trap, this article walks through the numbers so you can judge that for yourself. The stock last closed at US$12.33, with returns of 1.4% decline over 7 days, 48.0% decline over 30 days, 51.6% decline year to date and 67.6% decline over 1 year. This naturally raises questions about how the market is currently pricing the business. Recent news around Kyndryl has focused on its position as a standalone...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

Does EQT Offtake Deal and Rio Grande LNG Progress Change The Bull Case For NextDecade (NEXT)?

NextDecade is preparing to report its fourth-quarter results on March 2, 2026, as it works to bring the Rio Grande LNG facility online while managing ongoing losses. A recent 20-year offtake agreement with EQT for 1.5 million tonnes per annum stands out as a key milestone in de-risking future LNG sales from the project. We’ll now examine how progress at Rio Grande LNG, including the EQT offtake deal, is shaping NextDecade’s broader investment narrative. Capitalize on the AI infrastructure...
TSE:2802
TSE:2802Food

Ajinomoto (TSE:2802) Valuation Check After Trader Joe’s Frozen Rice Recall And Margin Concerns

What the Trader Joe’s recall means for Ajinomoto shareholders The large Trader Joe’s recall of Ajinomoto (TSE:2802) frozen chicken fried rice over potential glass contamination has brought attention to product quality and short-term cost pressures, with investors watching closely ahead of the May 6, 2026 earnings update. See our latest analysis for Ajinomoto. The recall headlines have arrived after a strong run in the shares, with Ajinomoto’s 30 day share price return of 43.25% and 1 year...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics Tresmi Launch And Record Revenue Shape Valuation Debate

United Therapeutics unveiled its new Tresmi soft mist inhaler platform, designed to improve patient experience in pulmonary hypertension treatment. The company reported record annual revenue alongside the Tresmi launch, underscoring progress across its commercial portfolio. Management also highlighted advances in late stage clinical programs, pointing to several upcoming trial readouts as key catalysts. United Therapeutics, traded as NasdaqGS:UTHR, comes into this news with a share price of...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Deepens ADAS Partnerships And Moves Closer To Level 4 Scale

Mobileye Global (NasdaqGS:MBLY) is adding Elektrobit’s Linux platform to its Mobileye Drive system to support Level 4 autonomous driving. The company recently secured a major U.S. OEM win for its advanced driver assistance systems, expanding its ADAS pipeline. Mobileye signed a SuperVision agreement with Mahindra & Mahindra, positioning itself as a Tier 1 supplier and opening new geographic markets. Mobileye Global, known for its driver assistance and autonomous driving technology, is...
BME:SAN
BME:SANBanks

Is It Too Late To Consider Santander (BME:SAN) After Its Strong Multi Year Rally?

If you are wondering whether Banco Santander's current share price offers value or is starting to look stretched, you are not alone. This article is here to unpack that question clearly. The stock recently closed at €10.79, with returns of 0.3% over 7 days, 1.8% over 30 days, 5.2% year to date and 77.7% over 1 year. The 3 year and 5 year returns of 211.4% and 318.6% indicate very large gains over those periods. Recent coverage of Banco Santander has focused on its position among European...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Is Aveanna Healthcare Holdings (AVAH) Still Attractively Priced After Its Recent Multi Year Surge

If you are wondering whether Aveanna Healthcare Holdings is still attractively priced after its recent run, you are not alone. This article focuses on what the current share price could imply about value. The stock last closed at US$7.36, with returns of 0.3% over 7 days, a 10.8% decline over 30 days, an 8.9% decline year to date, and a 72.8% gain over the past year, as well as a very large 3 year return of around 4x. Recent coverage has centred on Aveanna's role in home and pediatric...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Jazz Pharmaceuticals (JAZZ) Is Up 10.4% After Record Q4 Revenue And New Oncology Data Release

In late February 2026, Jazz Pharmaceuticals reported fourth‑quarter 2025 revenue of US$1,197.93 million and net income of US$203.45 million, contributing to record full‑year revenue of US$4.27 billion but a net loss of US$356.15 million. The company paired these results with guidance for 2026 revenue of US$4.25–4.50 billion and highlighted practice‑changing oncology data for zanidatamab and Ziihera, reinforcing its rare‑disease and cancer focus despite full‑year losses. Next, we’ll examine...
NasdaqGS:VRSN
NasdaqGS:VRSNIT

A Look At VeriSign (VRSN) Valuation After Recent Share Price Pullback

Why VeriSign Is On Investors’ Radar Today VeriSign (VRSN) is back in focus after a recent pullback, with the share price showing a negative return over the past month and past 3 months while longer term returns remain positive. See our latest analysis for VeriSign. The recent pullback, reflected in a 30 day share price return of 10.08% and a 90 day share price return of 9.54%, contrasts with a 3 year total shareholder return of 15.01% and a 5 year total shareholder return of 19.10%. This...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Does The Share Price Of uniQure (QURE) Reflect Its Gene Therapy Prospects?

If you are wondering whether uniQure’s current share price reflects its true worth, this breakdown is designed to help you weigh what you are paying against what you are getting. The stock closed at US$15.63, with returns of a 33.3% decline over 7 days, a 32.1% decline over 30 days, a 33.2% decline year to date, but an 18.9% gain over the past year, which may catch the eye of investors thinking about both risk and recovery potential. Recent news around uniQure has focused on its position in...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Assessing Core Scientific (CORZ) Valuation As AI Shift And Governance Changes Redefine The Business Model

Chair transition at Core Scientific comes as business model shifts toward AI infrastructure Core Scientific (CORZ) is back in focus after Chairman Jordan Levy told the board he will not stand for re election in 2026, as the company continues shifting toward AI focused data center operations. See our latest analysis for Core Scientific. The chairman news lands after a mixed share price stretch, with a recent 1 month share price return showing a 12.93% decline and a year to date share price...
ASX:CMM
ASX:CMMMetals and Mining

Capricorn Metals (ASX:CMM) Is Up Sharply After Maiden Fully Franked Dividend And Strong HY25 Profit - What's Changed

Capricorn Metals reported half-year 2025 results on 25 February 2026, with sales rising to A$327.48 million and net income reaching A$124.7 million, and declared a maiden fully franked interim dividend of A$0.05 per share, payable on 9 April 2026. This first-ever dividend, funded by substantially higher earnings and backed by reaffirmed FY26 production guidance, marks a shift toward returning cash to shareholders while continuing to invest in its gold projects. With the shares up very large...
LSE:RR.
LSE:RR.Aerospace & Defense

Is It Too Late To Consider Rolls-Royce (LSE:RR.) After Its 1 Year 81% Surge?

If you are wondering whether Rolls-Royce Holdings is still good value after its run up, this article will walk you through what the current price might be implying about the stock. The share price has been volatile recently, with a 0.2% decline over the last 7 days, a 10.4% gain over the last 30 days, an 11.4% return year to date, an 81.5% return over 1 year, and a very large 3 year and 5 year return that is well above 7x. Recent coverage around Rolls-Royce has focused on its position as a...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns

LeMaitre Vascular (NasdaqGM:LMAT) reported robust Q4 2025 and full-year 2025 financial results. The company announced a new US$100 million share repurchase program. Management approved a 25% dividend increase for shareholders. LeMaitre Vascular focuses on medical devices for vascular surgeons, so its performance tends to track demand for procedures that treat peripheral vascular disease and related conditions. The combination of strong quarterly and full-year 2025 figures with higher...
ENXTAM:ADYEN
ENXTAM:ADYENDiversified Financial

Adyen Taps Medius And Mesh To Deepen Corporate Spend Management Reach

Adyen has partnered with Medius to roll out a corporate card program with cashback rewards aimed at finance teams across Europe and the UK. The company has also teamed up with Mesh Payments to support local currency corporate cards and expense management for multinational clients. Together, these partnerships expand Adyen's presence in corporate payments and spend management solutions in Europe and the UK. Adyen (ENXTAM:ADYEN), currently trading at about €994.8 per share, is pushing further...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Assessing Coca-Cola Consolidated (COKE) Valuation After Record 2025 Earnings And Strong Share Price Momentum

Coca-Cola Consolidated (COKE) is back in focus after its 2025 earnings report, which highlighted record annual revenue and operating income alongside a sharp post-announcement share price run on heavy trading volume. See our latest analysis for Coca-Cola Consolidated. The earnings release sits on top of a powerful run in the stock, with a 30 day share price return of 35.57% and a year to date share price return of 35.08%, while the 5 year total shareholder return is close to 7x. This suggests...